Creating sustainable value for business and society.

For more than a century, our company has been inventing medicines and vaccines for the world’s most challenging diseases. Our 2017/2018 Corporate Responsibility Report illustrates our ongoing quest to save and improve lives through invention while also contributing to a healthier and more hopeful world.


Merck's corporate responsibility approach has four focus areas:

Access to Health

We have an important role and responsibility in improving access to medicines, vaccines and quality health care worldwide.


We recognize that our ability to excel depends on the integrity, knowledge, imagination, skill, diversity and teamwork of our employees.

Environmental Sustainability

A healthy planet is essential to human health and the sustainability of our business. We practice environmental stewardship.

Ethics and Transparency

Our goal is to lead the way to a healthier future. But we also care about how we get there together.

We’re pleased to report on our progress toward improving the health and well-being of people and animals around the world and our ongoing commitments to our stakeholders, as detailed in the 2017/2018 Corporate Responsibility Report. Highlights include:

Addressing 88 percent of the top 20 global burdens of disease with our products and pipeline.

Launching new initiatives to improve the health of underserved communities with chronic diseases and saving the lives of more women through Merck for Mothers, our global initiative to end preventable maternal deaths

Advancing progress towards our 2025 goal of having more than 50 percent of our purchased electricity come from renewable sources

Increasing our business with diverse suppliers by an additional 31% over 2016's 57% increase, exceeding our corporate goal of achieving $1.2 billion in spend in 2017.

Expanding the reach of our Animal Health business through new products and educational initiatives

Building an environment where diversity and inclusion is woven into the fabric of our culture

R&D Breakthroughs

Our R&D efforts prioritize promising research and clinical development that represent breakthrough science and target many of the world's most urgent global health challenges.

Our purpose in the world has not changed. By looking ahead to the next century, we can ensure that we can continue to fulfill our mission, balance the needs of the many stakeholders we serve and contribute to making this a better, healthier world for all. Future generations are counting on us.

- Ken Frazier, chairman and chief executive officer, Merck